Peripheral Nervous System Neoplasm — Trials

Peripheral Nervous System Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

261 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 1–20 of 20 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05891847	Non-interventional Study of Patients With PN NF1 Starting Selumetinib in Russia	terminated	—	150	AstraZenecaINDUSTRY	1	Jul 8, 2026	clinicaltrials
NCT03165721	A Phase II Trial of the DNA Methyl Transferase Inhibitor, Guadecitabine (SGI-110), in Children and Adults With Wild Type GIST,Pheochromocytoma and Paraganglioma Associated With Succinate Dehydrogenase Deficiency and HLRCC-associated Kidney Cancer	terminated	Phase 2	9	National Cancer Institute (NCI)NIH	1	Feb 18, 2026